{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:19:52Z","timestamp":1770833992309,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-06475-x","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:44:11Z","timestamp":1767591851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic susceptibility profile of bacterial isolates in paediatric cancer patients: a prospective cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Henry Kwadwo","family":"Hackman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Annison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuben Essel","family":"Arhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice Constance","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebenezer Krampah","family":"Aidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph Bubune","family":"Gawugah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Nwachuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin Ansah","family":"Agyei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"6475_CR1","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2147\/IDR.S183283","volume":"11","author":"A Fentie","year":"2018","unstructured":"Fentie A, Wondimeneh Y, Balcha A, Amsalu A, Adankie BT. Bacterial profile and antibiotic resistance pattern among cancer patients at university of Gondar Hospital, Northwest Ethiopia. Infect Drug Resist. 2018;11:2169\u201378. https:\/\/doi.org\/10.2147\/IDR.S183283.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"6475_CR2","doi-asserted-by":"publisher","first-page":"e0266919","DOI":"10.1371\/journal.pone.0266919","volume":"17","author":"M Worku","year":"2022","unstructured":"Worku M, Belay G, Tigabu A. Bacterial profile and antimicrobial susceptibility patterns in cancer patients. PLoS ONE. 2022;17(4):e0266919.","journal-title":"PLoS ONE"},{"key":"6475_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-319-04220-6_2","volume":"161","author":"TR Zembower","year":"2014","unstructured":"Zembower TR. Epidemiology of infections in cancer patients. Cancer Treat Res. 2014;161:43\u201389.","journal-title":"Cancer Treat Res"},{"key":"6475_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/IDR.S70486","volume":"7","author":"N Al-Mulla","year":"2014","unstructured":"Al-Mulla N, Elshafie SS, Janahi MA, Al-Nasser A, Chandra P, Taj-Aldeen SJ. Bacterial bloodstream infections and antimicrobial susceptibility patterns in paediatric hematology\/oncology patients after anticancer chemotherapy. Infect Drug Resist. 2014;7:289\u201399. https:\/\/doi.org\/10.2147\/IDR.S70486.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"6475_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/tropicalmed6020049","volume":"6","author":"G Shrestha","year":"2021","unstructured":"Shrestha G, Wei X, Hann K, Soe KT, Satyanarayana S, et al. Bacterial profile and antibiotic resistance among cancer patients with urinary tract infection in a National tertiary cancer hospital of Nepal. Trop Med Infect Dis. 2021;6(2):49. https:\/\/doi.org\/10.3390\/tropicalmed6020049.","journal-title":"Trop Med Infect Dis"},{"issue":"10","key":"6475_CR6","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1007\/s00520-011-1353-z","volume":"20","author":"C-I Kang","year":"2012","unstructured":"Kang C-I, Song J-H, Chung DR, Peck KR, et al. Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteraemia. Support Care Cancer. 2012;20(10):2371\u20138. https:\/\/doi.org\/10.1007\/s00520-011-1353-z.","journal-title":"Support Care Cancer"},{"key":"6475_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijid.2018.09.012","volume":"77","author":"T Mvalo","year":"2018","unstructured":"Mvalo T, Eley B, Bamford C, et al. Bloodstream infections in oncology patients at red cross war memorial children\u2019s Hospital, cape Town, from 2012 to 2014. Int J Infect Dis. 2018;77:40\u20137.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"6475_CR8","first-page":"15","volume":"25","author":"RS Uso","year":"2021","unstructured":"Uso RS, Taher CA. Bacterial profile, antibiotic resistance patterns, and associated factors among haematological malignancy patients in Erbil City. Zanco J Med Sci. 2021;25(2):15.","journal-title":"Zanco J Med Sci"},{"issue":"3","key":"6475_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/21505594.2016.1159366","volume":"7","author":"M Akova","year":"2016","unstructured":"Akova M. Epidemiology of antimicrobial resistance in bloodstream infections. Virulence. 2016;7(3):252\u201366. https:\/\/doi.org\/10.1080\/21505594.2016.1159366.","journal-title":"Virulence"},{"issue":"1","key":"6475_CR10","first-page":"23","volume":"55","author":"N Rabirad","year":"2014","unstructured":"Rabirad N, Mohammadpoor M, Lari AR, Shojaie A, Bayat R, Alebouyeh M. Antimicrobial susceptibility patterns of gram-negative bacteria isolated from septicaemia in children\u2019s medical Centre, Tehran, Iran. J Prev Med Hyg. 2014;55(1):23\u20136.","journal-title":"J Prev Med Hyg"},{"key":"6475_CR11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1186\/s13104-015-1701-z","volume":"8","author":"N Obeng-Nkrumah","year":"2015","unstructured":"Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES. Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Res Notes. 2015;8:742. https:\/\/doi.org\/10.1186\/s13104-015-1701-z.","journal-title":"BMC Res Notes"},{"key":"6475_CR12","doi-asserted-by":"publisher","unstructured":"Bhat S, Muthunatarajan S, Mulki SS, Bhat KA, Kotian KH. Bacterial infections among cancer patients: analysis of isolates and antibiotic sensitivity pattern. Int J Microbiol. 2021; 2021:8883700. https:\/\/doi.org\/10.1155\/2021\/8883700","DOI":"10.1155\/2021\/8883700"},{"issue":"1","key":"6475_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12879-020-4886-2","volume":"20","author":"F Chinowaita","year":"2020","unstructured":"Chinowaita F, Chaka W, Nyazika TK, et al. Sepsis in cancer patients residing in zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns. BMC Infect Dis. 2020;20(1):161. https:\/\/doi.org\/10.1186\/s12879-020-4886-2.","journal-title":"BMC Infect Dis"},{"key":"6475_CR14","doi-asserted-by":"publisher","unstructured":"Taj M, Farzana T, Shah T, Maqsood S, Ahmed SS, Shamsi TS. Clinical and microbiological profile of pathogens in febrile neutropenia in haematological malignancies: a single-centre prospective analysis. J Immunol Res. 2015; 2015:596504. https:\/\/doi.org\/10.1155\/2015\/596504","DOI":"10.1155\/2015\/596504"},{"issue":"2","key":"6475_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/646869","volume":"15","author":"M Rubio","year":"1994","unstructured":"Rubio M, Palau L, Vivas JR, et al. Predominance of gram-positive microorganisms as a cause of septicaemia in patients with haematological malignancies. Infect Control Hosp Epidemiol. 1994;15(2):101\u20134. https:\/\/doi.org\/10.1086\/646869.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"6475_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s15010-004-3049-5","volume":"32","author":"M Anatoliotaki","year":"2004","unstructured":"Anatoliotaki M, Valatas V, Mantadakis E, et al. Bloodstream infections in patients with solid tumours: associated factors, microbial spectrum and outcome. Infection. 2004;32(2):65\u201371. https:\/\/doi.org\/10.1007\/s15010-004-3049-5.","journal-title":"Infection"},{"issue":"5","key":"6475_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3109\/00365549109105183","volume":"23","author":"G G\u00fcnther","year":"1991","unstructured":"G\u00fcnther G, Bj\u00f6rkholm M, Bj\u00f6rklind A, et al. Septicaemia in patients with haematological disorders and neutropenia: a retrospective study of causative agents and their resistance profile. Scand J Infect Dis. 1991;23(5):589\u201398. https:\/\/doi.org\/10.3109\/00365549109105183.","journal-title":"Scand J Infect Dis"},{"key":"6475_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1086\/522998","volume":"45","author":"A Safdar","year":"2007","unstructured":"Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis. 2007;45:160\u20137. https:\/\/doi.org\/10.1086\/522998.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"6475_CR19","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/jac\/dks205","volume":"67","author":"A Gafter-Gvili","year":"2012","unstructured":"Gafter-Gvili A, Fraser A, Paul M, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. J Antimicrob Chemother. 2012;67(10):2250\u201361. https:\/\/doi.org\/10.1093\/jac\/dks205.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"6475_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","volume":"12","author":"GYC Cheung","year":"2021","unstructured":"Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547\u201369. https:\/\/doi.org\/10.1080\/21505594.2021.1878688.","journal-title":"Virulence"},{"issue":"10","key":"6475_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3109\/23744235.2015.1051105","volume":"47","author":"O Kara","year":"2015","unstructured":"Kara O, Zarakolu P, Ascioglu S, et al. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies. Infect Dis (Lond). 2015;47(10):686\u201393. https:\/\/doi.org\/10.3109\/23744235.2015.1051105.","journal-title":"Infect Dis (Lond)"},{"issue":"4","key":"6475_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jmii.2015.08.013","volume":"50","author":"F-T Kuo","year":"2017","unstructured":"Kuo F-T, Wang S-M, Shen C-F. Bloodstream infections in paediatric patients with acute leukemia: emphasis on gram-negative bacterial infections. J Microbiol Immunol Infect. 2017;50(4):507\u201313. https:\/\/doi.org\/10.1016\/j.jmii.2015.08.013.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"6475_CR23","first-page":"18","volume":"16","author":"T Butt","year":"2004","unstructured":"Butt T, Afzal RK, Ahmad RN, et al. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern. J Ayub Med Coll Abbottabad. 2004;16(1):18\u201322.","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"3","key":"6475_CR24","doi-asserted-by":"publisher","first-page":"e0173290","DOI":"10.1371\/journal.pone.0173290","volume":"12","author":"HK Kebede","year":"2017","unstructured":"Kebede HK, Gesesew HA, Woldehaimanot TE, Goro KK. Antimicrobial use in paediatric patients in a teaching hospital in Ethiopia. PLoS ONE. 2017;12(3):e0173290. https:\/\/doi.org\/10.1371\/journal.pone.0173290.","journal-title":"PLoS ONE"},{"key":"6475_CR25","doi-asserted-by":"publisher","first-page":"e2300313","DOI":"10.1200\/GO.23.00313","volume":"10","author":"SK Kipchumba","year":"2024","unstructured":"Kipchumba SK, Njuguna FM, Nyandiko WM. Bacterial isolates and characteristics of children with febrile neutropenia on treatment for cancer at a tertiary hospital in Western Kenya. JCO Glob Oncol. 2024;10:e2300313. https:\/\/doi.org\/10.1200\/GO.23.00313.","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"6475_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1345\/aph.1C292","volume":"37","author":"AH Mutnick","year":"2003","unstructured":"Mutnick AH, Kirby JT, Jones RN. Cancer resistance surveillance program: initial results from hematology\u2013oncology centres in North America (2000). Ann Pharmacother. 2003;37(1):47\u201356. https:\/\/doi.org\/10.1345\/aph.1C292.","journal-title":"Ann Pharmacother"},{"issue":"7","key":"6475_CR27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10096-014-2086-9","volume":"33","author":"E Montassier","year":"2014","unstructured":"Montassier E, Batard E, Gastinne T, et al. Recent changes in bacteraemia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2014;33(7):1227\u201343. https:\/\/doi.org\/10.1007\/s10096-014-2086-9.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"6475_CR28","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00277-018-3341-6","volume":"97","author":"C Cattaneo","year":"2018","unstructured":"Cattaneo C, Di Blasi R, Skert C, et al. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. Ann Hematol. 2018;97(9):1717\u201326. https:\/\/doi.org\/10.1007\/s00277-018-3341-6.","journal-title":"Ann Hematol"},{"issue":"12","key":"6475_CR29","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10096-013-1948-z","volume":"32","author":"E Montassier","year":"2013","unstructured":"Montassier E, L\u00e9ger J, Soucy-Faulkner A, et al. Enterobacteriaceae bacteraemia in neutropenic patients: risk factors and impact of empirical antibiotic therapy. Eur J Clin Microbiol Infect Dis. 2013;32(12):1611\u201320. https:\/\/doi.org\/10.1007\/s10096-013-1948-z.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"6475_CR30","first-page":"368","volume":"5","author":"U Bhabhor","year":"2018","unstructured":"Bhabhor U, Bhabhor H, Shingala H, Sinha M. Bacteriological study of bloodstream infection (BSI) in ICU patients. Int J Contemp Med Res. 2018;5(3):368\u201373.","journal-title":"Int J Contemp Med Res"},{"key":"6475_CR31","volume-title":"Manual of clinical microbiology","author":"A Balows","year":"2003","unstructured":"Balows A, Murray PR, Baron EJ, et al. Manual of clinical microbiology. 8th ed. Washington, DC: ASM; 2003.","edition":"8"},{"key":"6475_CR32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43046-023-00167-2","volume":"35","author":"N Adel","year":"2023","unstructured":"Adel N, Abdalla M, Rizk S, et al. Outcome and safety of colistin usage in paediatric cancer patients with carbapenem-resistant Enterobacteriaceae bacteraemia at children cancer hospital Egypt. J Egypt Natl Canc Inst. 2023;35:7.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"2","key":"6475_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/antibiotics12020405","volume":"12","author":"Y Madney","year":"2023","unstructured":"Madney Y, Elanany M, Aziz M, et al. Carbapenem-resistant Enterobacteriaceae among children with cancer: predictors of mortality and treatment outcome. Antibiot (Basel). 2023;12(2):405.","journal-title":"Antibiot (Basel)"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06475-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06475-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06475-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:39:09Z","timestamp":1770831549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-025-06475-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6475"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06475-x","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients (or guardian) gave written informed consent for participation. All data were anonymized, and individual patient identifiers were not recorded in the dataset. The study posed no risk to patients and adhered to the principles of the Declaration of Helsinki. The study protocol received approval from the KBTH institutional research review office (protocol ID: KBTH-ADM\/000201\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}